Literature DB >> 25661751

Diffuse alveolar haemorrhage secondary to propylthiouracil-induced vasculitis.

Catarina Ferreira1, Teresa Costa1, Ana Vieira Marques2.   

Abstract

Propylthiouracil is a drug used to treat hyperthyroidism. It can cause several side effects including pulmonary disorders that, although rare, can be severe. The authors describe the case of a woman treated with propylthiouracil who developed diffuse alveolar haemorrhage with severe respiratory failure and anaemia, which improved with discontinuation of the antithyroid drug and on starting systemic corticosteroid therapy. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25661751      PMCID： PMC4330446          DOI： 10.1136/bcr-2014-208289

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  28 in total

1.  Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.

Authors:  N Sera; K Ashizawa; T Ando; Y Abe; A Ide; T Usa; T Tominaga; E Ejima; N Yokoyama; K Eguchi
Journal:  Thyroid       Date:  2000-07       Impact factor: 6.568

2.  Thionamide-induced vasculitis: a case of alveolar haemorrhage secondary to propylthiouracil.

Authors:  Riad El-Fakih; Bassem M Chehab; Timothy Shaver
Journal:  J Intern Med       Date:  2008-06-26       Impact factor: 8.989

3.  Propylthiouracil-induced diffuse interstitial pneumonitis.

Authors:  K Miyazono; T Okazaki; S Uchida; Y Totsuka; T Matsumoto; E Ogata; K Terakawa; N Kurihara; T Takeda
Journal:  Arch Intern Med       Date:  1984-09

4.  Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil.

Authors:  S S Dhillon; D Singh; N Doe; A M Qadri; S Ricciardi; M I Schwarz
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

5.  Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.

Authors:  J Y Noh; T Asari; N Hamada; F Makino; N Ishikawa; Y Abe; K Ito; K Ito
Journal:  Clin Endocrinol (Oxf)       Date:  2001-05       Impact factor: 3.478

6.  Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.

Authors:  Yong-Xi Chen; Hai-Jin Yu; Li-Yan Ni; Wen Zhang; Yao-Wen Xu; Hong Ren; Xiao-Nong Chen; Xiang-Ling Wang; Xiao Li; Xiao-Xia Pan; Wei-Ming Wang; Nan Chen
Journal:  J Rheumatol       Date:  2007-11-01       Impact factor: 4.666

7.  Recurrent adult respiratory distress-like syndrome associated with propylthiouracil therapy.

Authors:  J C Chevrolet; G Guelpa; J A Schifferli
Journal:  Eur Respir J       Date:  1991-07       Impact factor: 16.671

Review 8.  Update in the diagnosis and management of pulmonary vasculitis.

Authors:  Stephen K Frankel; Gregory P Cosgrove; Aryeh Fischer; Richard T Meehan; Kevin K Brown
Journal:  Chest       Date:  2006-02       Impact factor: 9.410

9.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

10.  Propylthiouracil-induced lupus-like or vasculitis syndrome.

Authors:  Cuneyt Tetikkurt; Mehmet Yuruyen; Seza Tetikkurt; Nihal Bayar; Imran Ozdemir
Journal:  Multidiscip Respir Med       Date:  2012-07-17
View more
  1 in total

1.  Hepatitis B Virus-associated Vasculitis: Multiple Cavitary Masses in the Lung Mimicking Granulomatous Polyangiitis.

Authors:  Masahiro Nemoto; Kenjin Nishioka; Jun Fukuoka; Masahiro Aoshima
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.